Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Timing of supplemental parenteral nutrition in critically ill adults

Official title: The Effect of the Timing of Supplemental Parenteral Nutrition on the Prognosis of Critically Ill Patients (T-SPN): A Multicenter Randomized Controlled Trial

Run by The First Hospital of Jilin University · NCT07085455 · Data updated 2026-11-12

This trial will test whether starting supplemental parenteral (intravenous) nutrition on day 4 versus day 8 after ICU admission reduces 28-day death in critically ill adults who cannot meet calorie needs with enteral feeding.

More Critical Illness trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment946 (estimated)
SponsorThe First Hospital of Jilin University
Academic / other
Drugs / interventionschemotherapy
Locations2 sites (Changchun, Jilin and 1 other locations)
StatusRecruiting
StartedSeptember 9, 2025
Main results expectedJuly 20, 2027
Study endsJuly 20, 2029
Registry record updatedSeptember 15, 2025
Trial IDNCT07085455 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with at least one organ failure (SOFA ≥2) within 24 hours of ICU admission, expected to remain in the ICU >72 hours, able to start enteral nutrition within 48 hours but receiving <50% of target calories within 72 hours are eligible.

Probably not a fit

Patients who can tolerate full oral or full-dose enteral nutrition, those expected to die within 72 hours, pregnant or lactating women, or those with contraindications to parenteral nutrition are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter randomized controlled trial will assign critically ill adult ICU patients who are unable to reach 50% of their caloric needs by enteral nutrition to receive supplemental parenteral nutrition (SPN) beginning on day 4 versus day 8 after ICU admission. The primary outcome is 28-day all-cause mortality, with secondary outcomes including mortality at multiple time points through two years, 2-year EQ-5D-5L functional status, ICU length of stay, nutritional markers (prealbumin), muscle mass measurements, ICU-acquired infections, ventilator-free days, and metabolic adverse events. Baseline demographic, severity (APACHE II, SOFA) and nutritional data are collected within 24 hours of ICU admission and relevant clinical data are recorded throughout the ICU stay. The trial is conducted at participating ICUs with standardized protocols for enteral feeding, SPN administration, and outcome measurement.

Why it matters

Potential benefit: If successful, earlier supplemental parenteral nutrition could reduce short-term mortality and help preserve muscle and long-term functional outcomes by preventing prolonged energy deficits.

How similar studies have gone: Previous randomized trials of early versus delayed supplemental parenteral nutrition have produced mixed results—some showing no mortality benefit or increased complications—so the specific day-4 versus day-8 timing with detailed long-term functional and muscle endpoints is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥ 18 years
2. Failure of one or more organ systems within 24 hours of ICU admission, defined as Sequential Organ Failure Assessment (SOFA) score ≥ 2 in any single organ system
3. Expected ICU stay \> 72 hours
4. Able to initiate early enteral nutrition (EN) within 48 hours of ICU admission
5. Enteral nutrition providing \<50% of target caloric requirements within 72 hour Exclusion Criteria

1.Full oral intake or tolerance of full-dose EN; no need for SPN 2.Receiving palliative care or expected to die within 72 hours 3.Pregnant or lactating women 4.Long-term use of systemic corticosteroids or other immunosuppressive agents 5.Known malignancy currently receiving radiotherapy or chemotherapy 6.Contraindications to parenteral nutrition (PN) 7.Participation in another interventional clinical trial

Where it's running

  • The First Hospital of Jilin University
    Changchun, Jilin, China
    Recruiting
  • The First Hospital of Jilin University
    Changchun, Jilin, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.